HCPCS Code M1003

Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
Code effective Jan 01, 2023

HCPCS Section
Medical services

M1003 is a valid 2026 HCPCS code meaning Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy or (Tb scr 12 mo pri fst bio dz) for short. HCPCS M1003 has been effective since 01/01/2023 and applies to Medical care.

HCPCS Code Details - M1003
HCPCS Level II Code Section M - Medical services
HCPCS Code	`M1003`
Description	Long description: Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy Short description: Tb scr 12 mo pri fst bio dz
HCPCS Pricing indicator	`00` - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
Multiple pricing indicator	`9` - Not applicable as HCPCS not priced separately by part B or value is not established
Coverage code	`C` - Carrier judgment
BETOS² code	`Z2` - Undefined codes
HCPCS Action code	`N` - No maintenance for this code
Type of service	`1` - Medical care
Effective date	Effective Jan 01, 2023
Date added	Added Jan 01, 2019

HCPCS Code M1003

HCPCS Code Details - M1003

See also

HCPCS M1002 · Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given

HCPCS M1004 · Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)